Picton Mahoney Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-95,950
Closed -$17M 399
2020
Q1
$17M Buy
95,950
+83,119
+648% +$15.7M 0.96% 17
2019
Q4
$2.45M Buy
+12,831
New +$2.31M 0.17% 114
2016
Q4
Sell
-19,350
Closed -$4.46M 318
2016
Q3
$4.46M Sell
19,350
-1,600
-8% -$391K 0.3% 105
2016
Q2
$4.84M Sell
20,950
-25,900
-55% -$5.97M 0.3% 99
2016
Q1
$12.6M Sell
46,850
-2,855
-6% -$817K 0.8% 42
2015
Q4
$15.5M Sell
49,705
-45,120
-48% -$13.4M 0.93% 31
2015
Q3
$25.8M Buy
94,825
+37,125
+64% +$11.4M 1.5% 13
2015
Q2
$17.5M Sell
57,700
-800
-1% -$239K 0.86% 40
2015
Q1
$17.4M Buy
+58,500
New +$16.7M 0.67% 44

Other funds holding AGN

Picton Mahoney Asset Management's AGN Position: Q2 2020 in Review

Picton Mahoney Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 95,950 shares — an estimated $17M sold.

Picton Mahoney Asset Management first reported a position in AGN in Q1 2015 and held it in 9 quarters. The position peaked at $25.8M in Q3 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Picton Mahoney Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 95,950 Allergan plc shares in Q2 2020, an estimated $17M.
  • Picton Mahoney Asset Management first reported a position in Allergan plc in Q1 2015 and held it in 9 quarters.
  • Picton Mahoney Asset Management's Allergan plc position peaked at $25.8M in Q3 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2020, filed 5 Aug 2020.